Collectively, these findings position DNA‐PKcs‐mediated YAP1 phosphorylation and subsequent ferroptosis activation as critical drivers of DCM, unveiling potential therapeutic targets for intervention. The gene discussed is PRKDC; the disease is familial dilated cardiomyopathy.